Cardiopulmonary bypass (CPB) is a medical technique that temporarily takes over the function of the heart and lungs during cardiac surgery, allowing surgeons to perform intricate procedures on the heart. This sophisticated procedure involves diverting the patient's blood away from the heart and lungs, using a heart-lung machine that takes over the oxygenation and circulation of blood throughout the body. The machine removes carbon dioxide and adds oxygen to the blood, mimicking the natural functions of the heart and lungs. By employing CPB, surgeons can operate on a motionless and bloodless heart, facilitating complex cardiac surgeries that would be otherwise challenging or impossible. While essential for many cardiac procedures, the use of cardiopulmonary bypass does carry some risks, and ongoing research focuses on optimizing its techniques to minimize potential complications and enhance patient outcomes. The development of this technology has significantly advanced the field of cardiac surgery, enabling life-saving interventions and improving the overall success of complex heart surgeries.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain